Clinical Report: Feasibility of Exergaming for Mobility in Pediatric CP
Overview
This study evaluates the feasibility of a community-based exergaming intervention for enhancing mobility in pediatric patients with cerebral palsy (CP). It assesses the acceptability of the device, safety through adverse event reporting, and establishes primary outcome measures for future trials.
Background
Cerebral palsy is a prevalent childhood disability that significantly impacts mobility and quality of life. Traditional physiotherapy methods often face challenges in adherence, making innovative solutions like exergaming essential for improving engagement and outcomes. This study addresses the need for robust evidence on the efficacy of exergaming tailored for children with CP.
Data Highlights
No numerical data was provided in the source material.
Key Findings
The study explored the feasibility of a community-based exergaming randomized controlled trial (RCT).
It assessed the acceptability of the interactive exergaming device among pediatric patients with CP.
Primary outcome measures for assessing balance were established for future definitive trials.
Safety of the intervention was evaluated through the reporting of adverse events.
Indicators of efficacy for the exergaming device as a physiotherapy intervention were reported.
Clinical Implications
The findings suggest that exergaming could be a viable alternative to traditional physiotherapy, potentially enhancing adherence and engagement in home and community settings. Clinicians should consider integrating such innovative interventions into rehabilitation programs for children with CP.
Conclusion
This feasibility study lays the groundwork for future trials assessing the efficacy of exergaming in improving mobility in pediatric patients with cerebral palsy. Continued research is necessary to establish its clinical benefits.
This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from December 1 - 15.
